|
1
|
Kumar B, Cordell KG, Lee JS, Worden FP,
Prince ME, Tran HH, Wolf GT, Urba SG, Chepeha DB, Teknos TN, et al:
EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as
indicators of response to therapy and survival in oropharyngeal
cancer. J Clin Oncol. 26:3128–3137. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Geißler C, Tahtali A, Diensthuber M,
Gassner D, Stöver T and Wagenblast J: The role of p16 expression as
a predictive marker in HPV-positive oral SCCHN-a retrospective
single-center study. Anticancer Res. 33:913–916. 2013.PubMed/NCBI
|
|
3
|
Sritippho T, Pongsiriwet S,
Lertprasertsuke N, Buddhachat K, Sastraruji T and Iamaroon A: p16-a
possible surrogate marker for high-risk human papillomaviruses in
oral cancer? Asian Pac J Cancer Prev. 17:4049–4057. 2016.PubMed/NCBI
|
|
4
|
Shaughnessy JN, Farghaly H, Wilson L,
Redman R, Potts K, Bumpous J, Silverman C and Dunlap NE: HPV: A
factor in organ preservation for locally advanced larynx and
hypopharynx cancer? Am J Otolaryngol. 35:19–24. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wilson DD, Rahimi AS, Saylor DK, Stelow
EB, Jameson MJ, Shonka DC, Reibel JF, Levine PA and Read PW: p16
not a prognostic marker for hypopharyngeal squamous cell carcinoma.
Arch Otolaryngol Head Neck Surg. 138:556–561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ahn JS, Cho SH, Kim OK, Lee JK, Yang DH,
Kim YK, Lee JJ, Lim SC, Kim HJ, Chung WK and Chung IJ: The efficacy
of an induction chemotherapy combination with docetaxel, cisplatin,
and 5-FU followed by concurrent chemoradiotherapy in advanced head
and neck cancer. Cancer Res Treat. 39:93–98. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bae WK, Hwang JE, Shim HJ, Cho SH, Lee JK,
Lim SC, Chung WK and Chung IJ: Phase II study of docetaxel,
cisplatin, and 5-FU induction chemotherapy followed by
chemoradiotherapy in locoregionally advanced nasopharyngeal cancer.
Cancer Chemother Pharmacol. 65:589–595. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bae WK, Hwang JE, Shim HJ, Cho SH, Lee KH,
Han HS, Song EK, Yun HJ, Cho IS, Lee JK, et al: Multicenter phase
II study of weekly docetaxel, cisplatin, and S-1 (TPS) induction
chemotherapy for locally advanced squamous cell cancer of the head
and neck. BMC Cancer. 13:1022013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Temam S, Flahault A, Périé S, Monceaux G,
Coulet F, Callard P, Bernaudin JF, St Guily JL and Fouret P: p53
gene status as a predictor of tumor response to induction
chemotherapy of patients with locoregionally advanced squamous cell
carcinomas of the head and neck. J Clin Oncol. 18:385–394. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Bristow RG, Benchimol S and Hill RP: The
p53 gene as a modifier of intrinsic radiosensitivity: Implications
for radiotherapy. Radiother Oncol. 40:197–223. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Eisenhauer EA, Therasse P, Bogaerts J,
Schwartz LH, Sargent D, Ford R, Dancey J, Arbuck S, Gwyther S,
Mooney M, et al: New response evaluation criteria in solid tumours:
Revised RECIST guideline (version 1.1). Eur J Cancer. 45:228–247.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Frisch M, Hjalgrim H, Jaeger AB and Biggar
RJ: Changing patterns of tonsillar squamous cell carcinoma in the
United States. Cancer Causes Control. 11:489–495. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nasman A, Attner P, Hammarstedt L, Du J,
Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M,
Lindquist D, et al: Incidence of human papillomavirus (HPV)
positive tonsillar carcinoma in Stockholm, Sweden: An epidemic of
viral-induced carcinoma? Int J Cancer. 125:362–366. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Shin A, Jung YS, Jung KW, Kim K, Ryu J and
Won YJ: Trends of human papillomavirus-related head and neck
cancers in Korea: National cancer registry data. Laryngoscope.
123:E30–E37. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Dalianis T, Grün N, Koch J, Vlastos A,
Tertipis N, Nordfors C, Näsman A, Wendt M, Romanitan M, Bersani C,
et al: Human papillomavirus DNA and p16(INK4a) expression in
hypopharyngeal cancer and in relation to clinical outcome, in
Stockholm, Sweden. Oral Oncol. 51:857–861. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Rodrigo JP, Hermsen MA, Fresno MF,
Brakenhoff RH, Garcia-Velasco F, Snijders PJ, Heideman DA and
García-Pedrero JM: Prevalence of human papillomavirus in laryngeal
and hypopharyngeal squamous cell carcinomas in northern Spain.
Cancer Epidemiol. 39:37–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kanyilmaz G, Ekinci O, Muge A, Celik S and
Ozturk F: HPV-associated p16 INK4A expression and response to
therapy and survival in selected head and neck cancers. Asian Pac J
Cancer Prev. 16:253–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ang SH, Haaland B, Acharyya S, Thu MM,
Krisna SS, Hwang SG, Tan PH, Ng QS, Tan DS, Tai WM, et al:
Interactions between clinical factors, p16, and cyclin-D1
expression and survival outcomes in oropharyngeal and
hypopharyngeal squamous cell carcinoma. Head Neck. 37:1650–1659.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shinohara S, Kikuchi M, Tona R, Kanazawa
Y, Kishimoto I, Harada H, Imai Y and Usami Y: Prognostic impact of
p16 and p53 expression in oropharyngeal squamous cell carcinomas.
Jpn J Clin Oncol. 44:232–240. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim MJ, Ki MS, Kim K, Shim HJ, Hwang JE,
Bae WK, Chung IJ, Lee DH, Lee JK, Yoon TM, et al: Different protein
expression associated with chemotherapy response in oropharyngeal
cancer according to HPV status. BMC Cancer. 14:8242014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chung CH and Gillison ML: Human
papillomavirus in head and neck cancer: Its role in pathogenesis
and clinical implications. Clin Cancer Res. 15:6758–6762. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Peltenburg LT: Radiosensitivity of tumor
cells. Oncogenesis and apoptosis. Q J Nucl Med. 44:355–364.
2000.PubMed/NCBI
|
